Position in MRNA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$45,965,008
+$12,239,861 QoQ
Shares Held
904,823
-20.9% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Amundi holds $2,277,505,863 across 70 Biotechnology names. MRNA ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,009,798 | $780,210,323 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,472,496 | $657,528,360 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
747,544 | $247,339,881 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,088,773 | $148,168,440 | |
| 5 | INSM |
INSMED Inc
|
804,977 | $131,629,838 | |
| 6 | INCY |
Incyte Corp
|
1,003,969 | $94,493,561 | |
| 7 | MRNA |
Moderna, Inc.
This page
|
904,823 | $45,965,008 | |
| 8 | ARGX |
Argenx SE
|
61,433 | $44,861,448 |
All Filings in MRNA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,965,008 | 904,823 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $33,725,147 | 1,143,613 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $26,244,700 | 1,016,055 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $25,091,146 | 909,429 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $37,855,468 | 1,335,290 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $50,156,828 | 1,206,273 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $44,842,926 | 671,000 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $87,332,191 | 735,429 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $69,007,080 | 647,589 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $75,021,098 | 754,360 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $58,518,945 | 566,550 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $68,618,581 | 564,762 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $109,473,356 | 712,810 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $145,008,838 | 807,309 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $87,541,537 | 740,309 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $41,800,188 | 292,616 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $38,634,811 | 224,282 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $135,306,569 | 532,745 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $183,777,189 | 477,517 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $104,458,003 | 444,540 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||